This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2022 Mar 1;150(5):E3.

doi: 10.1002/ijc.32549. Epub 2021 Nov 25.

Withdrawn: circLgr4 drives colorectal tumorigenesis and invasion through Lgr4-targeting peptide

No authors listed

PMID: 31269234
DOI: 10.1002/ijc.32549

Free article

Withdrawn: circLgr4 drives colorectal tumorigenesis and invasion through Lgr4-targeting peptide

No authors listed. Int J Cancer. 2022.

Free article

. 2022 Mar 1;150(5):E3.

doi: 10.1002/ijc.32549. Epub 2021 Nov 25.

PMID: 31269234
DOI: 10.1002/ijc.32549

No abstract available

PubMed Disclaimer

Similar articles

The Role of LGR4 (GPR48) in Normal and Cancer Processes.
Ordaz-Ramos A, Rosales-Gallegos VH, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K. Ordaz-Ramos A, et al. Int J Mol Sci. 2021 Apr 29;22(9):4690. doi: 10.3390/ijms22094690. Int J Mol Sci. 2021. PMID: 33946652 Free PMC article. Review.
LGR4 and Its Role in Intestinal Protection and Energy Metabolism.
Li Z, Zhang W, Mulholland MW. Li Z, et al. Front Endocrinol (Lausanne). 2015 Aug 25;6:131. doi: 10.3389/fendo.2015.00131. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 26379625 Free PMC article. Review.
GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F, Yue J, Wang J, Zhang L, Fan R, Zhang H, Zhang Q. Liang F, et al. Med Oncol. 2015 Mar;32(3):49. doi: 10.1007/s12032-015-0486-1. Epub 2015 Jan 31. Med Oncol. 2015. PMID: 25636507
LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
Yue Z, Yuan Z, Zeng L, Wang Y, Lai L, Li J, Sun P, Xue X, Qi J, Yang Z, Zheng Y, Fang Y, Li D, Siwko S, Li Y, Luo J, Liu M. Yue Z, et al. FASEB J. 2018 May;32(5):2422-2437. doi: 10.1096/fj.201700897R. Epub 2017 Dec 21. FASEB J. 2018. PMID: 29269400 Free PMC article.
Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.
Luo W, Tan P, Rodriguez M, He L, Tan K, Zeng L, Siwko S, Liu M. Luo W, et al. J Biol Chem. 2017 Sep 15;292(37):15525-15537. doi: 10.1074/jbc.M116.771931. Epub 2017 Aug 2. J Biol Chem. 2017. PMID: 28768769 Free PMC article.

See all similar articles

Cited by

CircYthdc2 generates polypeptides through two translation strategies to facilitate virus escape.
Zheng W, Wang L, Geng S, Xu T. Zheng W, et al. Cell Mol Life Sci. 2024 Feb 15;81(1):91. doi: 10.1007/s00018-024-05148-9. Cell Mol Life Sci. 2024. PMID: 38361078 Free PMC article.
CircMIB2 therapy can effectively treat pathogenic infection by encoding a novel protein.
Zheng W, Wang L, Geng S, Yang L, Lv X, Xin S, Xu T. Zheng W, et al. Cell Death Dis. 2023 Aug 31;14(8):578. doi: 10.1038/s41419-023-06105-3. Cell Death Dis. 2023. PMID: 37652905 Free PMC article.
Circular RNAs: implications of signaling pathways and bioinformatics in human cancer.
Hu F, Peng Y, Fan X, Zhang X, Jin Z. Hu F, et al. Cancer Biol Med. 2023 Mar 2;20(2):104-28. doi: 10.20892/j.issn.2095-3941.2022.0466. Cancer Biol Med. 2023. PMID: 36861443 Free PMC article. Review.
The function and clinical implication of circular RNAs in lung cancer.
Ren W, Yuan Y, Peng J, Mutti L, Jiang X. Ren W, et al. Front Oncol. 2022 Oct 19;12:862602. doi: 10.3389/fonc.2022.862602. eCollection 2022. Front Oncol. 2022. PMID: 36338714 Free PMC article. Review.
CircRNA-Encoded Peptides or Proteins as New Players in Digestive System Neoplasms.
Meng E, Deng J, Jiang R, Wu H. Meng E, et al. Front Oncol. 2022 Jul 22;12:944159. doi: 10.3389/fonc.2022.944159. eCollection 2022. Front Oncol. 2022. PMID: 35936754 Free PMC article. Review.

See all "Cited by" articles

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley